10
PLEASE JOIN US FOR OUR 4TH ANNUAL Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering March 4-7, 2016 COURSE LOCATION Memorial Sloan Kettering Cancer Center ZUCKERMAN RESEARCH CENTER 417 East 68th Street between First and York Avenues NEW YORK To register and for more information, go to: www.mskcc.org/ hemonc review course

PLEASE JOIN US FOR OUR 4TH ANNUAL Hematology and …

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

P L E A S E J O I N U S F O R O U R 4 T H A N N U A L

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering

March 4-7, 2016 C O U R S E L O C A T I O N

Memorial Sloan Kettering Cancer CenterZUCKERMAN RESEARCH CENTER 417 East 68th Street between First and York Avenues

NEW YORKTo register and for more information, go to:

www.mskcc.org/ hemoncreviewcourse

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

COURSE OVERVIEW This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

EDUCATIONAL OBJECTIVESParticipants will gain an understanding of the:

■ State-of-the-science in diagnosis, staging, andtherapeutic management of solid tumor cancers;

■ State-of-the-science in diagnosis, staging, andtherapeutic management of hematologic cancers;

■ Recent treatment advances in solid tumor andhematologic oncology and their impact onmodern clinical practice.

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

FACULTY

MSK COURSE DIRECTOR

David Ilson MD PhDATTENDING PHYSICIANGastrointestinal Oncology Service Department of Medicine Division of Solid Tumor Oncology

MSK COURSE DIRECTOR

Craig Moskowitz MDSteven A. Greenberg Chair in Lymphoma Research

CLINICAL DIRECTOR Division of Hematologic Oncology

ATTENDING PHYSICIAN Lymphoma and Adult BMT ServicesMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine Weill Medical College of Cornell University

Philip Kantoff MDCHAIRMANDepartment of Medicine

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

Ghassan Abou-Alfa MD Associate Attending Physician Gastrointestinal Oncology Service Department of Medicine Division of Solid Tumor Oncology

Carol Aghajanian MD Attending Physician, Chief Gynecologic Medical Oncology Svc, Department of Medicine Division of Solid Tumor Oncology

Dean Bajorin MD Attending Physician Genitourinary Oncology Service Department of Medicine Division of Solid Tumor Oncology

George Bosl MD Attending Physician Genitourinary Oncology Service Department of Medicine Division of Solid Tumor Oncology Attending Physician, Chair Department of Medicine

Paul Chapman MD Attending Physician Melanoma and Sarcoma Service Department of Medicine Division of Solid Tumor Oncology

Andrea Cercek MD Assistant Attending Physician Gastrointestinal Oncology Service Division of Solid Tumor Oncology Department of Medicine

Mark Andrew Dickson MD Assistant Attending Physician Sarcoma Medical Oncology Service Division of Solid Tumor Oncology Department of Medicine

Sergio Andres Giralt MD Attending Physician, Chief Bone Marrow Transplant Service

Paul Hamlin MD Assistant Attending Physician Lymphoma Service Department of Medicine Division of Hematologic Oncology

Clifford Hudis MD Attending Physician, Chief Breast Medicine Service Division of Solid Tumor Oncology Department of Medicine

Alexander Lesokhin MDAssistant Attending Physician Myeloma Service Division of Hematologic Oncology Department of Medicine Assistant Attending Physician Bone Marrow Transplant Service

Simon Mantha MD Associate Attending Physician Hematology Service Department of Medicine Division of Hematologic Oncology

Michael Mauro MD Attending Physician Leukemia Service Department of Medicine Division of Hematologic Oncology

Michael Morris MD Associate Attending Physician Department of Medicine

Alison Moskowitz MDAssistant AttendingLymphoma Service Division of Hematologic OncologyDepartment of Medicine

Robert Motzer MD Attending Physician Genitourinary Oncology Service Department of Medicine Division of Solid Tumor Oncology

Eileen O’Reilly MBBCh BAO Associate Attending Physician Gastrointestinal Oncology Service Department of Medicine Division of Solid Tumor Oncology

Antonio Omuro MD Assistant Attending Neurologist Neurology Service Department of Neurology

Rekha Parameswaran MBBS Associate Attending Physician Hematology Service Department of Medicine Division of Hematologic Oncology Associate Attending Physician Blood Bank, Cytotherapy Lab Svc Department of Laboratory Medicine

Jae Park MD Assistant Attending Physician Leukemia Service Department of Medicine Division of Hematologic Oncology

Miguel Perales MD Associate Attending Physician Bone Marrow Transplant Service Department of Medicine Division of Hematologic Oncology

David Pfister MD Attending Physician, Chief Head and Neck Oncology Service Department of Medicine Division of Solid Tumor Oncology

Gregory Riely MD Vice ChairClinical Trials OfficeDepartment of Medicine

Charles Rudin MD PhD Attending Physician, Chief Thoracic Oncology Service Department of Medicine Division of Solid Tumor Oncology

Andrew Seidman MD Attending Physician Breast Cancer Medicine Service Department of Medicine Division of Solid Tumor Oncology

Susan Seo MD Associate Attending Physician Infectious Disease Service Department of Medicine Division of General Medicine

Zsofia Stadler MD Assistant Attending Physician Clinical Genetics Service Department of Medicine

Gerald Soff MD Attending Physician, Chief Hematology Service Division of Hematologic Oncology

David Spriggs MD Attending Physician, Division Head Vice Chair, Developmental Che-motherapy Division of Solid Tumor Oncology Department of Medicine

Martin Tallman MD Attending Physician, Chief Leukemia Service Department of Medicine Division of Hematologic Oncology

Anas Younes MD Attending Physician, Chief Lymphoma Service Department of Medicine Division of Hematologic Oncology

Anna Varghese MDAssistant AttendingLymphoma Service Division of Hematologic OncologyDepartment of Medicine

Marjorie Zauderer MD Assistant Attending Physician Thoracic Oncology Service Department of Medicine Division of Solid Tumor Oncology

Andrew Zelenetz MD PhD Attending Physician Lymphoma Service Department of Medicine Division of Hematologic Oncology

FACULTY

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

7:00am

8:00am

9:00am

10:00am

10:45am

11:30am

12:15pm

1:00pm

1:45pm

2:45pm

3:15pm

3:30pm

4:15pm

5:00pm

Friday, March 4

5:30pm

REGISTRATION & BREAKFAST

GRAND ROUNDS

New Developments in the Management of Prostate Cancer Philip Kantoff MD

Colon Cancer Leonard Saltz MD

Melanoma Paul Chapman MD

Testis Cancer George Bosl MD

Kidney Cancer Robert Motzer MDLUNCH

Urothelial Cancers Dean Bajorin MD

Non Small-Cell Lung Cancer Gregory Riely MD

Cancer Genetics Zsofia Stadler MD COFFEE BREAK

Advanced Breast Cancer Andrew Seidman MD

Prostate Cancer Michael Morris MD

Anal and Rectal CancerAndrea Cercek MD

Cancer of Unknown Primary Anna M. Varghese, MD

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

7:00am REGISTRATION & BREAKFAST

7:15am Mesothelioma Marjorie Zauderer MD

7:30am Small-Cell Lung Cancer Charles Rudin MD PhD

8:00am Ovarian Cancer Carol Aghajanian MD

845am Other Gynecologic Cancers Carol Aghajanian MD

9:30am Breast Cancer Adjuvant Therapy Clifford Hudis MD

10:15am COFFEE BREAK

10:30am Hepatocellular Cancer and Cholangiocarcinoma Ghassan Abou-Alfa MD

11:15am Pancreatic Cancer / Neuroendocrine Cancer Eileen O’Reilly MBBCh BAO

12:00pm LUNCH

1:00pm Gastric and Esophageal Cancer David Ilson MD PhD

1:45pm Head and Neck / Thyroid Cancer David Pfister MD

2:30pm Pharmacology I David Spriggs MD

3:15pm COFFEE BREAK

3:30pm Pharmacology II David Spriggs MD

4:00pm Central Nervous System Cancers Antonio Omuro MD

4:30pm Sarcoma Mark Andrew Dickson MD

5:00pm Infectious Disease Susan Seo MD

Saturday, March 5

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

7:00am

8:00am

8:30am

9:00am

9:45am

10:00am

11:00am

11:45am

1:00pm

1:30pm

2:00pm

2:30pm

3:15pm

3:45pm

BREAKFAST

Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma and Hairy Cell Leukemia Jae Park MD

Myelodysplastic Syndromes and Myeloproliferative Disorders Michael Mauro MD

Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Martin Tallman MDCOFFEE BREAK

Multiple Myeloma Alexander Lesokhin MD

Indolent Lymphomas Andrew Zelenetz MD PhDLUNCH

T-Cell / Cutaneous LymphomaAlison Moskowitz MD

Hodgkin Lymphoma Craig Moskowitz MD

Aggressive Lymphomas (Diffuse Large B-Cell Lymphoma) Paul Hamlin MD

Mantle Cell Lymphoma and Waldenström’s Macroglobulinemia Anas Younes MD

Hematopoietic Stem Cell Transplantation (Autologous / Allogeneic) Sergio Andres Giralt MD

Complications of Hematopoietic Stem Cell Transplantation Miguel Perales MD

Sunday, March 6

Hematology and Medical Oncology Board Review: Contemporary Practice from Memorial Sloan Kettering 2016

www.mskcc.org/hemoncreviewcourse

7:00am

8:00am

8:45am

9:30am

10:15am

10:30am

11:15am

11:30am

BREAKFAST

Interpretation of Coagulation Testing Simon Mantha MD

Approach to the Bleeding Patient Rekha Parameswaran MD

Thrombosis:Pathophysiology and Management Gerald Soff MD

COFFEE BREAK

Thrombocytopenia Gerald Soff MD

Update on Use of the New Oral Anticoagulants Simon Mantha MD

CLOSING REMARKS

Monday, March 7

TARGET AUDIENCEPhysicians who are either oncology fellows in training, or practicing oncologists in both academic and private practice.

COURSE DESIGNThis course is comprised of lectures and interactive audience participation encouraging the intellectual exchange of ideas between faculty and participants.

EVALUATIONA course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.

OUTCOMES MEASUREMENT SURVEYSix months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.

ACCOMMODATIONSIf you are traveling to MSK from out of town, we recommend that you reserve hotel rooms as early as possible. To make the planning a little easier, MSK has negotiated rates at select hotels in Manhattan. For a list of these hotels, please go to:www.mskcc.org/accommodations.

ACCREDITATION STATEMENTMSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

AMA CREDIT DESIGNATION STATEMENTMSK designates this live activity for a maximum of 26.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 26.25 AMA PRA Category 1 Credits™.

REGISTRATION

$1,400 MDs, PhDs and DOs

$875 Fellows, Residents and RNs

Registration fee includes an electronic syllabus and other related hand-out materials, continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with special dietary needs. The course will be held on the campus of Memorial Sloan Kettering on the Upper East Side of Manhattan. Breakfast and lunch will be provided daily.

To register to attend, please go to:

www.mskcc.org/hemoncreviewcourseOr contact:

OFFICE OF CONTINUING MEDICAL EDUCATIONMemorial Sloan Kettering Cancer Center633 Third Avenue, 12th floor, New York, New York 10017

(646) 227-2025 | [email protected]

2016

Low Dose Radiation Safety March 1-2

HemOnc Board Review Course March 4-7CAR T-Cell March 9-11

Cancer as an Evolving and March 12-15 Systemic Disease (Geoffrey Beene)

NYSTS March 18-19

Early Onset Colorectal Cancer March 18-19

Improving Cancer Care in the April 15 Perioperatve Period

Multidisciplinary Spine Oncology Symposium April 22-23

International Ovarian Cancer Conference April 29-30

Pelvic MRI Course April 24-27

The State of Cardio-Oncology 2016 April 29-30

Aging in Cancer June 24

Pathology of Neoplastic Disease May 2

Dermatopathology May 8-10

Lymphoma Symposium May 13-14

Radioactive Seed Localization Course May 13

Oncologic Imaging: The MSK May 18-21 Disease Management Team Approach

State of the Art in Thrombosis May 15 and Hemostasis

National Corporate Medical Associates June 16-17

Oncologic Imaging Course in Dubrovnik June 30-July 2

Breast DMT Retreat September

PET/CT Course Sept 16-17

Endobronchial Ultrasound, Sept 22-23 Interventional Bronchoscopy

Advanced Breast Imaging Sept 9-11 with MR Workstation

Advances in Thoracic Surgical Oncology Sept 23-24

Intraoperative Imaging Technologies October 21 for Cancer Detection and Treatment

Myeloproliferative Neoplasms October 16

Alumni Meeting October 21

Dermatologic Care in Oncology October 21

Dermoscopy: Intermediate Course Oct 28-29

Body Imaging Oncologic Course Nov 4-5 in Italy (MSK and Univ. of Pisa)

Contemporary Management of Nov 18-20 Complex Skin Cancers

Musculoskeletal Tumor Pathology TBD

Please be sure to mark your calendars

for upcoming

2016 MSK CME COURSES

To register or for more information, go to:

www.mskcc.org/cme

Or contact the:

OFFICE OF CONTINUING

MEDICAL EDUCATION

MEMORIAL SLOAN KETTERING

CANCER CENTER633 Third Avenue, 12th Floor

New York, NY 10017

ACCREDITATION STATEMENTMSK is accredited by the Accreditation Council for

Continuing Medical Education to sponsor continuing

medical education for physicians.

For course updates, follow:

facebook.com/mskcmeor on Twitter: @mskcme